These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 1924244

  • 21. [Immunological correction in progressive pulmonary tuberculosis].
    Maslennikov AA, Kamenev VF, Kolomiets VM.
    Probl Tuberk Bolezn Legk; 2007; (9):30-3. PubMed ID: 18038603
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Immunological characteristics of the side-effects of antibacterial preparations in pulmonary tuberculosis patients].
    Samarash VS.
    Vrach Delo; 1986 Nov; (11):25-6. PubMed ID: 3825037
    [No Abstract] [Full Text] [Related]

  • 25. [Some regularities of an immune response in patients with pulmonary tuberculosis and drug-resistant Mycobacterium strains].
    Sakharova IIa, Ariél' BM, Knoring BE, Skvortsova LA, Vasil'eva GIu, Vishnevskiĭ BI, Pogodaeva SS.
    Probl Tuberk Bolezn Legk; 2008 Nov; (12):22-7. PubMed ID: 19230184
    [Abstract] [Full Text] [Related]

  • 26. [Clinical evaluation of side effects during chemotherapy of tuberculosis].
    Eĭnis VL, Tuganova VE.
    Probl Tuberk; 1970 Nov; 48(6):18-22. PubMed ID: 5447927
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Immune responsive features in patients with pulmonary tuberculosis complicated by intestinal dysbacteriosis].
    Lineva ZE.
    Probl Tuberk; 1997 Nov; (2):32-3. PubMed ID: 9235581
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].
    Karachunskiĭ MA, Gergert VIa, Iakovleva OB.
    Probl Tuberk; 1997 Nov; (6):59-60. PubMed ID: 9503939
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy.
    Hirsch CS, Toossi Z, Othieno C, Johnson JL, Schwander SK, Robertson S, Wallis RS, Edmonds K, Okwera A, Mugerwa R, Peters P, Ellner JJ.
    J Infect Dis; 1999 Dec; 180(6):2069-73. PubMed ID: 10558973
    [Abstract] [Full Text] [Related]

  • 36. [Side effects of antibacterial drugs in patients with tuberculosis].
    Sergeev IS, Magnitskiĭ VA.
    Ter Arkh; 1976 Dec; 48(5):140-9. PubMed ID: 781894
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Specific immunity of patients with newly detected tuberculosis during chemotherapy].
    Evdokimov VN.
    Probl Tuberk; 1984 Sep; (9):33-8. PubMed ID: 6334298
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.